CHRDL1 and gastric cancer: Previous studies (Deng et al., 2022; 2021; Yuan et al., 2024) have identified CHRDL1 as a prognostic marker for LUAD, with lower expression observed in low-risk gastric cancer patients (Hu et al., 2018).